Skip to main content

Thomas Kassberg

Equibles does not estimate personal net worth.

Get an email with a short summary when Passage BIO, Inc. publishes a filing, an earnings call transcript or a press release.

Get PASG alerts

About Thomas Kassberg

Thomas Kassberg is recorded as Board Member at Passage BIO, Inc. (PASG) since September 10, 2024. Passage BIO, Inc. reported in an 8-K filed September 10, 2024 that Thomas Kassberg was appointed Class I director and as a member of the Audit Committee of the Board, effective September 10, 2024. Passage BIO, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Passage BIO, Inc. includes Peter Smith, Ph.D. (CEO), William Chou (CEO and Board Member), William Chou, M.D. (CEO and Board Member) and 6 others.

“On September 9, 2024, the board of directors (the "Board") of Passage Bio, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Thomas Kassberg as a Class I director and as a member of the Audit Committee of the Board, effective as of September 10, 2024 (the "Appointment Date").”
Passage BIO, Inc. Form 8-K, filed September 10, 2024 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2024-09-10–present

Leadership on record at Passage BIO, Inc.

Recent activity